Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

…, UA Weber, A Potekhin, F Bachmann… - The Journal of …, 2021 - Am Soc Clin Investig
Novel mRNA-based vaccines have been proven to be powerful tools in combating the global
pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently …

Autoantibodies against thrombospondin type 1 domain–containing 7A induce membranous nephropathy

…, U Helmchen, J Gerth, F Bachmann… - The Journal of …, 2016 - Am Soc Clin Investig
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
and one-third of patients develop end-stage renal disease (ESRD). Circulating …

Interventions for preventing bone disease in kidney transplant recipients

…, DO McGregor, F Bachmann… - Cochrane Database …, 2019 - cochranelibrary.com
Background People who have chronic kidney disease (CKD) have important changes to
bone structure, strength, and metabolism. Children experience bone deformity, pain, and …

[HTML][HTML] Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

…, M Oellerich, V Proß, C Stahl, M Choi, F Bachmann… - JCI insight, 2022 - ncbi.nlm.nih.gov
Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …

Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients

…, E Seelow, J Waiser, B Zukunft, F Bachmann… - Journal of clinical …, 2022 - mdpi.com
Mortality from COVID-19 among kidney transplant recipients (KTR) is high, and their
response to three vaccinations against SARS-CoV-2 is strongly impaired. We retrospectively …

B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients

…, M Choi, F Bachmann… - Journal of the …, 2021 - journals.lww.com
Background Accumulating evidence sugges ts solid organ transplant recipients, as opposed
to the general population, show strongly impaired responsiveness toward standard SARS-…

Experience with belatacept rescue therapy in kidney transplant recipients

…, M Dürr, T Braun, F Bachmann… - Transplant …, 2016 - Wiley Online Library
In kidney transplant recipients with chronic graft dysfunction, long‐term immunosuppression
with calcineurin inhibitors ( CNI s) or mTOR inhibitors ( mTOR i) can be challenging due to …

eHealth in transplantation

…, B Zukunft, B Osmonodja, F Bachmann… - Transplant …, 2021 - Wiley Online Library
eHealth (“electronic” Health) is a new field in medicine that has the potential to change medical
care, increase efficiency, and reduce costs. In this review, we analyzed the current status …

Early postoperative basal insulin therapy versus standard of care for the prevention of diabetes mellitus after kidney transplantation: a multicenter randomized trial

…, M Bergmann, S Hödlmoser, F Bachmann… - Journal of the …, 2021 - journals.lww.com
Methods This open-label, multicenter randomized trial compared 133 kidney transplant
recipients given intermediate-acting insulin isophane for postoperative afternoon glucose≥ 140 …

Pregnancy following kidney transplantation-impact on mother and graft function and focus on childrens' longitudinal development

F Bachmann, K Budde, M Gerland, C Wiechers… - BMC pregnancy and …, 2019 - Springer
Background Pregnancy after kidney transplantation has been considered as high risk for
maternal and fetal complications. After careful patient selection successful pregnancies are …